S

Sage Therapeutics

749 employees

SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neuroscience
brain disorders
Health Care
Therapeutics
Medical
Mental Health
Brain Health
CNS disorders

Date founded

2010

Funding rounds raised

Total raised

$650M

from 8 investors over 8 rounds

S

Sage Therapeutics raised $650M on November 27, 2020

Investors: Biogen Idec

S

Sage Therapeutics raised $38M on March 13, 2014

Investors: ARCH Venture Partners, OrbiMed Advisors, Third Rock Ventures and Foresite Capital

S

Sage Therapeutics raised $20M on October 16, 2013

Investors: Third Rock Ventures and ARCH Venture Partners

S

Sage Therapeutics raised $35M on October 18, 2011

Investors: Third Rock Ventures

FAQ